Presented by
Management Forum
Key guidance on how to use the ISO 10993 series of standards and successfully apply a risk management approach to the biological evaluation of medical devices. *Includes:* Interactive workshops and discussion sessions
★★★★★ "The course was very insightful and gave me a better understanding of the process and required effort... more (12)"
16-17 September 2024 »
from £1299
The ISO 10993 series of standards covering biological evaluation of medical devices is well established and regulatory authorities worldwide expect compliance. In Europe, compliance with the standards is the easiest way to meet the essential product safety requirements of the MDR and understanding a risk management approach to biological safety is essential.
This seminar will provide key guidance on how to use the standards and successfully apply a risk management approach to the biological evaluation of medical devices. There will be plenty of time during the programme for interactive discussion with experts in this field.
Benefits of attending:
This course is of our range of Medical Devices training courses - now also including Medical Devices Cyber Security training to help improve your data security.
The event will be of particular importance to those in the medical device industry from the following departments:
It will also be of interest to regulatory authorities, Notified Bodies and CROs supporting the medical device industry.
Philip Clay is Director and principal toxicologist with Chorley Consulting. He is a UK and European registered toxicologist and specialises in product safety assessment with over 30 years’ experience in toxicology and safety assessment. He is a BSI committee member on CH/194 (Biological evaluation of medical devices) and Principal Expert for WG6 (Mutagenicity, carcinogenicity and reproductive toxicity).
Philip established his reputation as a genetic toxicologist working within the agrochemical, chemical and pharmaceutical industries. He has contributed to many expert panels, helping to shape the testing guidelines and strategies in place today. More recently, this experience and depth of understanding has been applied to designing safety assessment programmes for medical devices and consumer healthcare products for a wide range of clients. Philip is presently a member of a Consumer Healthcare Products Association (CHPA) expert group lobbying US FDA regarding the use of in vitro data in the assessment of the biocompatibility of medical devices.
He has extensive experience in the biological safety evaluation of a wide range of medical devices from Class 1 consumer healthcare devices through to Class 3 implantable devices. He is an experienced speaker at scientific conferences and has delivered training on biological safety evaluation around the world.
Rona is a Senior Safety Assessor with Chorley Consulting. She holds a first class MSci in Biomedical Sciences from the University of Aberdeen. Additionally, she has attended training courses on the Practical Application of Toxicology in Drug Development and also Personal Animal License Course, Modules 1-3. She spent her year industry with a multinational consumer healthcare and medical device manufacturer, gaining experience in the safety assessment of medical devices. She joins Chorley from a Scientist role with British American Tobacco where she honed her toxicology skills performing toxicological risk assessment for harm reduction products. Rona brings to Chorley experience gained with a healthcare medical device manufacturer as well toxicological risk assessment skills gained during her time with BAT.
During her time with Chorley, Rona has rapidly developed her skills in performing toxicological risk assessments of extractable and leachable data including the use of in silico tools for the prediction of toxicological effects. She has also developed her presentation skills, having presented a number of on-line training modules around various aspects of Biological Evaluation of Medical Devices.
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
Please contact us for pricing if you are interested in booking 5 or more delegates
16-17 September 2024
Classroom
Rembrandt Hotel
London
09:00-17:00 UK (London)
Course code 13872
Optional £240/€312/$360 per night
Until 12 Aug
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.
The course was very insightful and gave me a better understanding of the process and required effort. Excellent and knowledgeable speaker.
Sep 18 2023
Lambert Luong
QA-officer, Enraf-Nonius B.V.
Sep 18 2023
Good training. I liked both the assessments and examples provided.
Sílvia Alexandra Fernandes
QA &RA Director, Nordeberg Medical AB
Sep 18 2023
My expectation were to understand the key steps of the processes and the challenges linked to each steps. It has been fully accomplished!
Cecile Artus-Arduise
Head of Medical Affairs, LABORATOIRE HRA PHARMA
Sep 18 2023
Very knowledgeable person, who knows how to involve the attendants and make the subject more tangible. The quizzes force you to rehearse, remember and also apply the information that was given during the course.
Anne-Marie van Maurik
QA-manager, Enraf-Nonius B.V.
Sep 18 2023
My expectation were to understand the key steps of the processes and the challenges linked to each steps. It has been fully accomplished! The training and the speaker were very great.
Cecile Artus-Arduise
Head of Medical Affairs, LABORATOIRE HRA PHARMA
Feb 8 2022
Excellent and very informative course
Anna Gabbott
Regulatory Affairs Specialist, Vernacare
Feb 8 2022
Excellent and very informative course
Anna Gabbott
Regulatory Affairs Specialist, Vernacare
Feb 8 2022
Very informative but also personalised
Paul Fineran
Healthcare Technology Portfolio Project and Development Manager, University of Edinburgh
Feb 8 2022
Very detailed content and patient presenters
Elena Couzens
Service Development Manager, MET Limited
Feb 8 2022
the course was well presented and clear enough for a complete beginner to understand.
Sarah Hinchliffe
Microbiology Manager, Xiros Ltd
Oct 31 2019
I learned a lot from this course, the speakers were great and they encouraged questions from the attendees. The quiz summarized each part well. My overall opinion is very positive and I would recommend it to my colleagues.
Avital Levertov
Regulatory Affairs Manager, Elcam Medical ACAL
Oct 31 2019
It was a good course with good shared discussion about many topics and issues. The course material was well organized.
Elen Lasri
Regulatory Affairs Specialist, Elcam Medical ACAL
United Kingdom
Netherlands
Sweden
Denmark
Ireland
Switzerland
United States of America
Australia
Belgium
Finland
France
Germany
Israel
Italy
Pakistan
2 days
Typical duration
Pricing from:
We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.
Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:
Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to: